查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197820

眼科診斷市場——增長、趨勢和預測 (2023-2028)

Ophthalmology Diagnostics Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 100 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，眼科診斷市場預計將以約 5.8% 的複合年增長率增長。

隨著診所和初級保健中心的關閉，COVID-19 在早期階段對眼科診斷市場產生了重大影響。 結果，到眼科就診的患者數量急劇減少。 然而，一旦限制放鬆，該行業就會強勁反彈。 近兩年來，眼科診斷設備銷量增加、新產品上市、眼科評估診斷需求增加，帶動了市場復甦。

推動市場增長的主要因素是青光眼、眼睛疲勞、白內障、色盲和糖尿病性視網膜病變等各種眼病在全球的流行。 這些疾病需要早期診斷才能有效治療。 此外，快速增長的老年人口正在增加世界可避免失明的負擔並提高醫療保健意識。 這將導致定期進行健康檢查並提振市場。 例如，根據 BrightFocus Foundation 的 2021 年更新，超過 300 萬美國人患有青光眼。 其中，40 歲以上的 270 萬人患有最常見的開角型青光眼。 2022 NEI 更新估計，在 2010 年至 2050 年間，白內障患者人數將從 2440 萬增加一倍至 5000 萬。 因此，眼部相關疾病負擔的增加以及對其篩查和診斷的增加預計將對市場增長產生重大影響。 此外，根據2022年4月發表的論文“Frontiers”，在中老年人糖尿病視網膜病變（DR）的檢測中，定期篩查（每年篩查或前5年每年篩查2次）優於不定期篩查，發現超標

綜上所述，相信未來眼科診斷市場將不斷擴大。 然而，眼科診斷設備的高成本和熟練專業人員的短缺阻礙了市場的增長。

眼科診斷市場趨勢

在眼科診斷市場，手術評估板塊有望佔據較大市場份額

由於白內障和糖尿病視網膜病變等疾病的高患病率，預計手術評估部分在預測期內將佔據很大份額。 隨著白內障手術的增加，全世界對手術評估的需求不斷增長。 例如，CDC 報告稱，17.2% 的 40 歲以上美國人至少有一隻眼睛患有白內障（約 2050 萬人）。 到 2028 年，預計將有超過 3000 萬人患有白內障。

與眼科手術領域相關的產品發布、併購和研究將推動市場增長。 例如，2021 年 7 月，佳能推出了廣域掃描光學相干斷層掃描 (OCT)“Xephilio OCT-S1”，單次掃描可捕獲高達 23 x 20 毫米的高分辨率圖像。 該產品在 APACRS-SNEC 聯合活動中展示給了眼保健醫生。 佳能的深度掃描掃描光源技術可實現約 80 度的廣角操作。 此外，2022 年 3 月，專注於治療青光眼的全球醫療器械公司 New World Medical 更新了 STREAMLINETM 手術系統的發布計劃。 STREAMLINE 是一種一次性設備，採用直觀的點擊脈衝技術，是一線的無植入系統，旨在在小梁網中進行精確的房角切開術。 此外，眼科粘性手術裝置 (OVD) 可以一步以小增量輸送到施累姆氏管中。 此外，2021 年 7 月，強生 (J&J) Vision 將在全球推出超聲乳化 (FACO) 系統，該系統旨在提高外科醫生在白內障手術中的效率和舒適度。底部。 超聲乳化是最常見的白內障手術類型，當白內障導致晶狀體變渾濁時，醫生可以將其乳化並取出眼內晶狀體。

因此，考慮到上述因素，手術評估部分很可能在預測期內出現增長。

北美預計在預測期內見證眼科診斷市場的增長

由於白內障和糖尿病性視網膜病變等眼病的患病率急劇上升，以及老年人口的顯著增加，預計在預測期內，北美的整體眼科診斷市場將實現健康增長在美國... 例如，在 2021 年青光眼宣傳月中，COS-SCO 表示每年有超過 800,000 名加拿大人患有青光眼。 在宣傳月期間，加拿大人口老齡化等因素導致疾病負擔增加。 未來幾年，青光眼很可能在加拿大流行，預計這將推動市場增長。

此外，政府在眼科領域的舉措不斷增加也推動了市場增長。 例如，每年 3 月 6 日至 12 日舉辦世界青光眼周，以提高人們對青光眼的認識。 2022年，本次活動的宗旨是“世界光明，保護視力”。 目的是引起人們對青光眼定期篩查和早期診斷的關注。 此外，市場參與者已採取各種策略，如產品發布、開發、收購、合作、合併和擴張，以增加其市場份額。 例如，2021年1月，愛爾康在美國商業化推出了非衍射焦深人工晶狀體（IOL）“AcrySof”。 此外，2022 年 3 月，掌上眼底相機供應商 Epipole 在紐約 Vision Expo East 2022 上推出了一款新的眼底相機 epiCam。 epiCam 是一款高功率、超便攜、無線視網膜相機，可通過 epipole 的新 VDO（視頻直接檢眼鏡）平台捕捉高分辨率實時視頻和伴隨的活體視網膜靜止圖像。

綜上所述，預計北美地區在預測期內將實現增長。

光學診斷市場競爭對手分析

眼科診斷市場競爭適中，由幾家大型企業組成。 一些主要參與者正在開發新技術，以與市場上現有的暢銷產品競爭。 此外，主要參與者正在引入直銷力量和分銷商的組合，以在全球市場上佔據一席之地。 此外，一些主要參與者已建立合作夥伴關係以發展其市場地位。 目前主導市場的公司包括 Ziemer Ophthalmic Systems AG、Topcon Corporation、Carl Zeiss AG、Metall Zug Ag 和 Alcon Inc。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 由於糖尿病增加，全球眼科疾病發病率增加
    • 政府加大了對視力障礙控制的支持力度以及眼科設備的快速發展
  • 市場製約因素
    • 眼科設備和治療費用飆升
    • 新興國家/地區的眼科醫生缺乏認識和技能
  • 波特的五力分析
    • 供應商的議價能力
    • 買方/消費者議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模 - 百萬美元）

  • 按產品分類
    • 角膜地形圖師
    • 眼底照相機
    • 檢眼鏡
    • 華僑城掃描儀
    • 檢影鏡
    • 折光儀
    • 其他
  • 通過申請
    • 視網膜評估
    • 青光眼測試
    • 手術評估
    • 折射檢查
    • 其他
  • 最終用戶
    • 醫院
    • 專科診所
    • 其他
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Marco Ophthalmic Inc.
    • Topcon Corporation
    • NIDEK CO., LTD
    • Carl Zeiss Meditec AG
    • Alcon Inc.
    • Lumenis Ltd
    • Metall Zug Group
    • Lumibird Group
    • EssilorLuxottica
    • Ziemer Ophthalmic Systems AG
    • Canon

第7章 市場機會今後動向

簡介目錄
Product Code: 67811

The ophthalmic diagnostics market studied was anticipated to grow with a CAGR of nearly 5.8% during the forecast period.

COVID-19 profoundly impacted the ophthalmic diagnostic market during the initial phases since the clinics, and primary care centres were closed due to the lockdown. As a result, the number of patients visiting for ophthalmic consultation was reduced abruptly. However, when the restrictions were relaxed, the sector recovered strongly. Over the last two years, an increase in ophthalmic diagnostics device sales, new product launches, and increased demand for ophthalmic evaluations and diagnostics are driving the market recovery.

The primary factors driving the market's growth are the various ophthalmic disorders' global prevalence, such as glaucoma, eyestrain, cataract, colourblindness, diabetic retinopathy, etc. All these prevalences necessitate early-stage diagnosis for efficient treatment. Also, a steep rise in the geriatric population results in the global burden of avoidable blindness and the growth of healthcare awareness. It leads to regular health check-ups and fuels the market. For instance, as per the 2021 update from BrightFocus Foundation, more than 3 million Americans are living with glaucoma. Out of these numbers, 2.7 million of whom-aged 40 and older are affected by its most common form, open-angle glaucoma. According to the 2022 NEI update, the estimated number of people who have had cataracts is likely to get doubled from 24.4 million to 50 million between 2010 and 2050. Hence, the rising burden of eye-related disorders and increased screening and diagnosis of the same is projecting a significant impact on the market growth. Furthermore, according to the article Frontiers published in April 2022, periodic screening (annual or biannual screening in the first five years) had exceeded nonperiodic screening in detecting diabetic retinopathy (DR) in the middle-to-advanced age group.

As per the above facts, the ophthalmic diagnostics market will likely witness growth over the forecast. However, the high cost of ophthalmic diagnostic devices and the lack of skilled professionals hinder the market growth.

Ophthalmology Diagnostics Market Trends

The Surgical Evaluation Segment is Expected to Hold a Significant Market Share in the Ophthalmic Diagnostics Market

The surgical evaluation segment is expected to witness a significant share over the forecast period owing to the higher prevalence of cataracts and diabetic retinopathy. It will lead to cataract surgeries resulting in higher demand for surgical evaluation globally. For instance, CDC reported that 17.2% of Americans over 40 years of age have a cataract in at least one eye (about 20.5 million people). By 2028, it is expected that over 30 million people will be likely to have cataracts.

Product launches, mergers, acquisitions, and research related to the ophthalmology surgical field will fuel the market growth. For instance, in July 2021, Canon launched Xephilio OCT-S1, a wide-field swept-source Optical Coherence Tomography (OCT) capable of capturing high-resolution images of up to 23 x 20 mm in a single scan. The product was unveiled to the eyecare medical practitioners at the APACRS-SNEC joint event. Canon's deep-scanning swept-source technology enables it to operate at an extensive-angle of around 80 degrees. Furthermore, in March 2022, New World Medical, a global medical device company focused on glaucoma interventions, updated its launch plans for the STREAMLINETM Surgical System. STREAMLINE, a single-use device featuring the intuitive ClickPulse Technology is a first-line implant-free system designed to create precise goniotomies in the trabecular meshwork. It also delivers small amounts of Ophthalmic Viscosurgical Device (OVD) into the canal of Schlemm in one unified step. Additionally, in July 2021, Johnson & Johnson (J&J) Vision globally launched its phacoemulsification (phaco) system, developed to provide surgeons with improved efficiency and comfort during cataract surgery. Phacoemulsification, the most frequent cataract surgical approach, allows doctors to emulsify and remove the eye's internal lens when it becomes cloudy due to cataracts.

Hence, considering the above factors, the surgical evaluation segment will likely witness growth over the forecast period.

North America is Expected to Witness a Growth in the Ophthalmology Diagnostics Market Over the Forecast Period

North America is expected to witness healthy growth in the overall ophthalmic diagnostics market throughout the forecast period due to a steep rise in the prevalence of ophthalmic disorders, such as cataracts and diabetic retinopathy, along with the massive growth of the geriatric population in the US. For instance, in 2021, the COS-SCO, during Glaucoma Awareness Month, stated that glaucoma affects more than 800,000 Canadians annually. During the awareness month, factors such as Canada's aging population contributed to a rise in disease burden. Glaucoma has the potential to become an epidemic in Canada in the coming years, which is expected to drive market growth.

Furthermore, increased government initiatives in the field of eyecare boost market growth. For instance, World Glaucoma Week is celebrated every year on March 6 to 12 to raise awareness regarding glaucoma. In 2022, the initiative's objective was "the world is bright; save your sight." Its goal was to alert people to have regular check-ups and an early diagnosis of glaucoma. Moreover, the market players adopted various strategies, such as product launches, developments, acquisitions, collaborations, mergers, and expansions, to increase market share. For instance, in January 2021, Alcon commercially launched a non-diffractive extended depth of focus intraocular lens (IOL), AcrySof, in the United States. Furthermore, in March 2022, Epipole, a provider of handheld fundus cameras, launched its new epiCam fundus camera at the Vision Expo East 2022 in New York City. The epiCam is a high-powered, ultra-portable, wireless fundus camera that captures live high-resolution video footage of the living retina and accompanying still images using epipole's new video direct ophthalmoscopy (VDO) platform.

Considering the above facts, North America is expected to witness growth over the forecast period.

Ophthalmology Diagnostics Market Competitor Analysis

The ophthalmic diagnostics market is moderately competitive and consists of several major players. Few key players are developing novel technologies to compete with the existing blockbuster products trending in the market. Furthermore, critical players in the firm are implementing a combination of direct sales force and distributors to gain a global market position. Again, a few key players are entering into partnerships to develop their market position. Some companies currently dominating the market are Ziemer Ophthalmic Systems AG, Topcon Corporation, Carl Zeiss AG, Metall Zug Ag, and Alcon Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increased Global Incidence of Ophthalmic Disorders Coupled with Rise in Diabetes
    • 4.2.2 Rise in Government Support to Control Visual Impairment and Rapid Advancements in the Ophthalmic Devices
  • 4.3 Market Restraints
    • 4.3.1 Higher Cost of the Ophthalmic Devices and Treatment
    • 4.3.2 Lack of Awareness and Skilled Ophthalmologists in Emerging Nations
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Product
    • 5.1.1 Corneal Topographers
    • 5.1.2 Fundus Cameras
    • 5.1.3 Ophthalmoscopes
    • 5.1.4 OCT Scanners
    • 5.1.5 Retinoscopes
    • 5.1.6 Refractors
    • 5.1.7 Others
  • 5.2 By Application
    • 5.2.1 Retinal Evaluation
    • 5.2.2 Glaucoma Detection
    • 5.2.3 Surgical Evaluation
    • 5.2.4 Refraction Assessment
    • 5.2.5 Others
  • 5.3 By End-user
    • 5.3.1 Hospitals
    • 5.3.2 Speciality Clinics
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United states
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Marco Ophthalmic Inc.
    • 6.1.2 Topcon Corporation
    • 6.1.3 NIDEK CO., LTD
    • 6.1.4 Carl Zeiss Meditec AG
    • 6.1.5 Alcon Inc.
    • 6.1.6 Lumenis Ltd
    • 6.1.7 Metall Zug Group
    • 6.1.8 Lumibird Group
    • 6.1.9 EssilorLuxottica
    • 6.1.10 Ziemer Ophthalmic Systems AG
    • 6.1.11 Canon

7 MARKET OPPORTUNITIES AND FUTURE TRENDS